Skip to main content

Connect Biopharma Holdings Ltd

corporate_fare Company Profile

Connect Biopharma Holdings Ltd

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed CNTB - Latest Insights

CNTB
Apr 23, 2026, 9:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Connect Biopharma's Rademikibart Phase 2 Asthma/COPD Trials Progress as Planned After Positive Interim Review
Sentiment: Positive
View Wiseek Article
CNTB
Apr 01, 2026, 4:30 PM EDT
Filing Type: 4
Importance Score:
9
Director James Huang Makes $4 Million Open Market Purchase Following Positive News
Sentiment: Positive
View Wiseek Article
CNTB
Apr 01, 2026, 4:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Major Investor Panacea Venture Acquires $4.0M in Private Placement at Premium, Director Huang Locks Up Shares
Sentiment: Positive
View Wiseek Article
CNTB
Mar 31, 2026, 4:15 PM EDT
Source: Wiseek News
Importance Score:
8
Connect Biopharma's 2025 10-K Reveals Near-Zero Revenue, Widened $(1.00) EPS Loss
Sentiment: Negative
View Wiseek Article
CNTB
Mar 31, 2026, 4:10 PM EDT
Filing Type: 10-K
Importance Score:
8
Connect Biopharma Reports Widened Losses, Secures Funding, and Announces Positive Rademikibart Clinical Data
Sentiment: Neutral
View Wiseek Article
CNTB
Mar 31, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Connect Biopharma Secures $20.2M Equity Financing at Premium, Extends Runway, and Reports Positive Clinical Data
Sentiment: Positive
View Wiseek Article
CNTB
Mar 30, 2026, 9:20 AM EDT
Source: Reuters
Importance Score:
9
Rademikibart Achieves 'Best-In-Class' Potential in Pivotal Phase 3 Atopic Dermatitis Study
Sentiment: Positive
View Wiseek Article
CNTB
Mar 30, 2026, 7:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Connect Biopharma Secures $20.2M Private Placement
Sentiment: Neutral
View Wiseek Article